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Abstract
Universal phenotyping techniques that can discriminate among various states of biological systems have great potential.
We applied 557 fluorescent library compounds to NCI’s 60 human cancer cell-lines (NCI-60) to generate a systematic
fluorescence phenotypic profiling data. By the kinetic fluorescence intensity analysis, we successfully discriminated the
organ origin of all the 60 cell-lines.
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Introduction
A principal challenge for functional genomics is to identify
genotypes that are associated with a specific phenotype. Recent
advances in gene expression profiling and next-generation
sequencing (NGS) technology have driven significant improve-
ments in high-throughput genotyping. [1,2] However, unlike the
well established genotyping platforms, there is no standard
quantitative methods for phenotyping yet. [3] Phenotypes can be
defined at many different levels; e.g., biochemical, or physiological
characteristics which can be measured at a cellular level, or
behaviour or clinical history at an organism level. [4] Each
phenotypic measurement has been used for further study on a
case-by-case basis. For instance, behaviour and brain imaging
pattern have frequently been used for phenomic character in
neuroscience, [5–8] and CD (cluster of designation)-marker based
biochemical phenotypes are extensively used to discriminate
between cell types in various fields. [9,10] However, there are
not yet universal phenomic parameter that can be applied to
diverse screening formats. [11]
We envisioned that a fluorescent probe library would have great
potential to identify a set of universal phenomic parameters due to
their uniform phenotypic readout (fluorescence signal), easy dose
controls, high sensitivity to micro-environments, and structural
diversity at the molecular level. Our group has recently developed
fluorescent libraries and reported a series of imaging probes in
glucagon secreting cells, [12] differentiated myotube cells, [13] and
pluripotent stem cells. [14] Even in case the intracellular targets
are not clearly defined, the phenotypic signature could be used for
a variety of applications. [15] More importantly, depending on the
properties of the fluorescent probe, high content information could
be extracted from a single fluorescence image. [16,17] Accord-
ingly, fluorescent phenotype profiling using synthetic probes could
reveal subtle differences in biochemical characteristics. In this
paper, we report the first fluorescence intensity-based cellular
phenomic profiling study using a diversity-oriented fluorescence
library (DOFL) and NCI-60 cancer cell lines.
To demonstrate the phenomic scale of fluorescence image-
based screening methodology, 60 human cancer cell lines (NCI-
60) of the National Cancer Institute’s Developmental Therapeutics
Program were chosen. These cells were selected based on the
following the two reasons. (i) it is the largest standard collection of
broad cancer cell types. The NCI-60 set contains cancers of 9
different origins, including leukemia, melanomas, renal, breast,
colon, lung, CNS, prostate, and ovarian carcinomas. (ii) rich
biochemical background information about the collection is
available to public. The characteristics of the NCI-60 set have
been profiled at the genomic, [18,19] proteomic, [20] and drug
effect level, [21–23] and those data can be easily applied to further
‘‘omics’’ studies. While various profiling approaches have been
widely explored to characterize the NCI-60 cell-lines, a systematic
fluorescent probe-based profiling has not been pursued yet.
Results and Discussion
Fluorescent probes and fluorescence phenotyping
Combination of rosamine (RS) and BODIPY (BD) fluorophore
libraries (240 rosamine [24] and 317 BODIPY [12] compounds, 557
compounds in total) were used to generate fluorescence phenotyping
data. As previously reported, these compounds showed good cell
permeability, and broad absorbance (l abs=480,616 nm) and
fluorescence emission (l em=530,656 nm) ranges with a broad
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assays, we utilized a whole cell fluorescence image-based screening
platform, which would provide integrated cellular characteristics, so
called high-contents screening. The large-scale profiling was
performed using an automated fluorescence microscope system
(ImageXpress Micro, Molecular Devices, Inc.). NCI-60 cells were
plated in thin-bottom 384-well plates at 70% confluency, and 557
fluorescent compounds were added to different wells at two final
concentrations of 250 nM and 500 nM. The fluorescence images
were obtained both in the FITC and the TRITC channels to cover
the broad range of spectra of the probes. Fluorescent images were
taken from two independent sites of each well for 3 time points
(1 hour, 24 hours and 48 hours), and all the experiments were
duplicated. All together, 1,604,160 images (557 probes660 cancer
cells62 concentrations62 channels62s i t e s 63 time points62
duplicates) were collected. A representative fluorescence image data
of BD-46 is presented in Figure 1 and the details of the plate design is
described in Figure S1. From these fluorescence images, many
different kinds of features, such as morphology, texture, or intensity
could be extracted and used as a phenotypic signature. [25] Notably,
the staining intensities and the pattern of localizations varied in
individual cell-lines, even though all cells were stained with an
identical amount of BD-46.
Quantitative fluorescence intensity profiling of NCI-60
cell lines
Among various possible parameters, we focused on the
fluorescence intensity of the cells, since the image processing
method was straightforward and the processed data was less
dependent to the analysis algorithm than others. To further
suppress the artifact from the batch-to-batch variations (this is
especially important in this study due to the long data acquisition
time over 2 years), we decided to use fluorescence intensity fold
change over the time (intensity kinetic profile), rather than the
absolute value of the intensity. Firstly, we measured the mean
values of the fluorescence intensity of the cells, and the intensity
pattern for different cell-lines were analyzed by their intensity
kinetic profile (fold change of the intensity values at 48 h over 1 h;
the data processing protocols are described in the experimental
methods). Then, we analyzed the overall fluorescence intensity
pattern change of the NCI-60 set of cell-lines by heatmap analysis
and hierarchical clustering (Fig. 2). In general, lung, colon, and
ovarian cancer cells were well classified by the simple clustering.
On the other hand, from a perspective of chemical structure,
fluorescent compounds that shares same classes of xanthone
derivative structure (e.g. RS-A, RS-E, and RS-K series) exhibited
Figure 1. Fluorescence phenotype profiling workflow and representative fluorescence phenotype profile; BD-46 (500 nM) was
added to 60 human cancer cell-lines and fluorescence phenotype profiles were measured after 1 h using automated fluorescence
microscopy.
doi:10.1371/journal.pone.0032096.g001
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(Fig. S2).
Interestingly, a remarkable signature was observed for the RS-K
series of compounds. These compounds initially showed low
fluorescence intensity, but after 24 h, their fluorescence was
dramatically increased only in specific set of cell-lines (HCT-116,
HT29, COLO205, HCC-2998, EKVX, HOP-62, NCI-H460,
NCI-H322M, and NCI-H23). Moreover, fluorescence response
profiles were highly correlated with the probe structure and cancer
cell type (Fig. S2). For example, a series of RS-K compounds (K1,
K3, K4, K14, K15, K16, and K17) exhibited fluorescence turn-
on effects in lung and colon cancer cells (Fig. S3), and RS-E
compounds (E1, E3, E7, and E29) showed turn-on responses in
lung cancer cells (Fig. S4). Although the fluorescence response of
Figure 2. Hierarchical clustering of the fluorescence response phenotype. Fluorescence intensity fold changes were clustered for the 557
fluorescent probes (x-axis) across the 60 cancer cell lines (y-axis). Fold=(fluorescence intensity at 48 h incubation)/(fluorescence intensity at1h
incubation).
doi:10.1371/journal.pone.0032096.g002
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each compounds showed subtle but distinct signature. In
particular, RS-K series compounds showed turn-on effects
towards broad ranges of lung cancer cell, but they differs response
pattern depending on the 9-phenyl ring structure of rosamine (Fig.
S3). It is also noteworthy to point out some of these probes
distinguish specific cell lines from identical cancer origin. RS-E1,
RS-E3 and RS-E7 compounds selectively turned on only in
ACHN cells among renal cancer cells (Fig. S5). Moreover, they
exhibited specific response to SW60 cells, but not for the rest of 6
colon cancer cells.
Another cell line specific profile was observed with the RS-C3
compound. RS-C3 induced a strong fluorescence turn-on effect
only in KM12 cells, a human colon cancer cell line, among 60 cell
lines (Fig. 3). Compared with the average fluorescent intensities in
other NCI-60 cells, RS-C3 exhibited an exceptional 5.64-fold
higher intensity in the KM12 cells. To explore the functional
characteristic of the KM122 cells that induce selective fluorescence
phenotype, we analyzed mRNA expression data of the NCI-60 cell
lines. Based on the mRNA expression data of GSE5846,
differentially expressed genes (DEGs) that up-regulated in KM12
cells (Log2(Fold) .1.5) were selected, and their gene annotation
information were analyzed. KEGG pathway and gene ontology
analyses identified five pathways that exhibit significant difference
(P value ,0.001) between KM12 cells and all the other NCI60
cells, such as cell communication, hematopoietic cell lineage, urea
cycle and metabolism of amino groups and p53 signaling pathway
(Table S3, S4). With these combinations of DEGs expression, it is
possible to discriminate KM12 cells out of other NCI60 cell lines,
and up-regulated profile of these genes are unique functional
signature of KM12 cells. Since fluorescence phenotype of RS-C3
shows collective information of such DEGs profile within a single
fluorescence image as intensity changes, this probe has potential
for sensing similar functional signature of other cell lines. While it
was not clear at the moment what kinds of endogenous
biomolecule are directly interacting with this probe, it could be
utilized to visually identify a colon cancer cell line (KM12) among
60 cancer cell lines after 24 h pre-incubation.
Discrimination of cancer cell origin
For quantitative pattern analysis, the intensity kinetic profiles
were further examined using linear discriminant analysis (LDA) to
classify the cancer cell types. LDA is a commonly used
classification method especially for high dimensional data for
reduction of dimensionality. By applying LDA to kinetic profiles, it
was possible to evaluate fold change responses of each chemical
probe for optimum cancer cell identification, and generate score
function to predict the identity of cells even each probe does not
show specific response to single cell line. The minimum fluorescent
probe set that could discriminate 9 cancer cell types was chosen by
a forward step-wise variable selection algorithm, and 37
differentially responding fluorescent probes were selected (Fig.
S6). Surprisingly, all 60 cancer cells were successfully clustered on
an LDA score plot (Fig. 4), and 98% were correctly assigned to
each of the original groups using jackknifed cross-validation (Table
S1). LDA scores are arbitrary unit values representing maximum
identity prediction, and our result showed the first and second
highest LDA scores were enough to discriminate 60 cell lines in
terms of cancer origin (Table S2). It is worth noting that
classification using a combination of both BD and RS probes
was much more successful as determined by cross-validation than
any combination of either RS or BD probes alone (Table 1). This
result implies that the chemical diversity of the fluorescent probes
used to generate the intensity profile significantly affected the
results of the cancer type classification. Another interesting aspect
of selected 37 probes set is that none of these probes are selective
to single cell or cancer types. They showed unique response
patterns for multiple cell-lines, and the target cell was not always
limited within identical cancer types. We believe such selective
responses originated by specific biochemical signature or integrat-
ed intact environments of target cell types.
Conclusion
In short, we report the first fluorescence intensity-based
phenotype profiling of 60 human cancer cell-lines (NCI-60) using
synthetic fluorescent probes. Structural diversity of the fluores-
cent probes seems to be a critical factor for the generation of
distinct phenotypes, and our results showed that 60 cancer cell-
lines are all successfully discriminated in terms of 9 cancer cell
origins. The most emphasis in cancer research has been focused
on pathogenesis and metastasis, and metastasis research has been
stagnated because of a lack of reliable tracking technique that
could visualize a specific origin of cancer cells. Fluorescence
compounds that probe specific origin of cancer cell could not
only provide a new window for metastasis research, but also be
utilized for cancer diagnosis and progression monitoring.
Although this study has limitations in that we performed
identification of cancer cells origin using only in vitro cancer cell
lines, our results provided a clue that combinations of fluorescent
probes could distinguish complex and subtle differences of
cancer cells. Based on the response pattern, the better
identification result was achieved when more fluorophore
scaffolds were used, and the fluorescence intensity profiles were
highly correlated with the chemical structure of the fluorescent
probes and cancer types. These findings demonstrate the
practical utility of the diversity-oriented fluorescence library
approach in universal cell phenotyping.
Methods
Diversity-oriented fluorescence library preparation
The rosamine and BODIPY library compounds were prepared
according to previously reported protocols, and the compound
structures and characterization data has been reported. [12,24,26]
All compounds were stored at 220uC in microtilter plates in solid
form, and stock solutions were made by dissolving the compounds
in DMSO prior to screening.
NCI-60 cancer cell culture
The NCI-60 cell-lines were obtained from the National Cancer
Institute. All NCI-60 cell-lines were cultured as described in the
distributor’s manual. Briefly, cells were cultured in a high-glucose
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented
with 10% FBS and 1% antibiotics.
Quantitative fluorescence intensity analysis
Mean values of the fluorescence intensities were calculated using
Matlab 7.9.0 (R2009b). In our dataset, 4 images represented each
experimental condition (2 duplicate62 images/well). We com-
bined the 4 images using the cat function in Matlab to optimize IO
processing. To minimize the background effect, only the
fluorescence intensity values for area that were positive for Otsu’s
threshold were used to calculate the average value. The graythresh
and im2bw functions in the Matlab image processing module were
used to calculate Otsu’s threshold and the cell area selection. All
quantitative image processing batch jobs were computed using a
16-node PC cluster for 3 days.
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e32096Figure 4. LDA score plot for the intensity kinetic profiles. x-, and y-axis represents the highest and 2
nd highest LDA scores by cell scoring
function (Table S2). The 60 cancer cell lines were labelled according to the origin of cancer type; CNS: red, colon: purple, leukemia: orange, lung:
green, melanoma: pink, breast: dark green, prostate: pale pink, ovarian: grey, and renal: olive.
doi:10.1371/journal.pone.0032096.g004
Figure 3. Fluorescence intensity profile of RS-C3 (500 nM) against NCI-60 cells after 24 h incubation and the corresponding
fluorescent images. (a) bar graph of kinetic fold change (b) fluorescence images of 60 cancer cell lines.
doi:10.1371/journal.pone.0032096.g003
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Linear discriminant analysis (LDA) was performed using fold
change values of the fluorescence intensities between 48 hour and
1 hour incubation points. Probe selection was processed by
forward-stepwise variable selection algorithum in SYSTAT
(version 13).
NCI-60 gene expression and pathway analysis
The mRNA expression patterns for the NCI-60 set of cell lines
were downloaded from the NCBI gene expression omnibus (GEO)
database. The GSE5846 data were analyzed using GenePlex v3.0
DEG finding and Pathway analysis modules (ISTECH, Inc.).
Supporting Information
Figure S1 Schematics of NCI-60 assay format. We used
384 well plate for high throughput fluorescent imaging. 60 cells
were divided into 13 subsets (each set contains less than 5 cell
lines), and 2 fluorescent probes are tested with each of the subsets
in an individual well plate. Since the culture media evaporate fast
in edge wells, first and last two columns were not used for the
assay.
(TIF)
Figure S2 SAR of fluorescent probes in phenotype
profile. Hierarchical cluster of fluorescent response phenotype
reveals structural relationship of fluorescent probe. Fluorescent
intensity changes pattern of 557 fluorescent probes (x-axis) against
60 cancer cells (y-axis) were clustered. Fold=(fluorescent intensity
after 48 h incubation)/(fluorescent intensity after 1 h incubation).
(TIF)
Figure S3 Fluorescence intensity profile of RS-K series.
(a) Fluorescence response profile of RS-K15 in NCI60 cells and
fluorescence images of lung cancer cell lines. First and second row
images were taken after 1 h and 24 h after probe treatment
respectively. All 4 images for each experimental condition are
shown. (b) Fluorescence intensity bar graph pattern of RS-K series
towards 60 cancer cell line.
(TIF)
Figure S4 Fluorescence intensity profile of RS-E series.
(TIF)
Figure S5 Cell line specific response of RS-E series
compounds among renal and colon cancer origin.
Fluorescence intensity bar graph of RS-E1, RS-E3, and RS-E7
compounds for cancer cells from (a) colon and (b) renal origin.
(TIF)
Figure S6 Structures of 37 selected fluorescence probes
from LDA. Probes were choosed based on step-wise forward
automatic variable selection algorithm with alpha-to-enter: 0.150
and alpha-to-remove: 0.150 criteria using SYSTAT v13.
(TIF)
Table S1 Jackknifed cross-validation matrix for three
set of fluorescent probes.
(XLS)
Table S2 LDA score function and coefficient of selected
fluorescent probes.
(XLS)
Table S3 Selected KEGG pathways based on DEGs of
KM12. P-values were calculated by Fisher’s exact test.
(XLS)
Table S4 Top 20 biological processes from gene ontology
annotation of DEGs in KM12 cell.
(XLS)
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